AKT1 and carcinoma: Chien et al. showed carcinoma-associated mesenchymal stem cells (CA-MSC) secretions can promote AKT and XIAP phosphorylation and suggested that tumor microenvironment as well as the extracellular matrix (ECM) can alter tumor's response to chemotherapy [32].